Compounded Mounjaro (Tirzepatide): Legal Status, Risks
Compounded Mounjaro: what compounded versions are, their FDA status, and the risks.
- Active ingredient
- tirzepatide
- FDA status
- Compounded copies are not FDA approved
Mounjaro: a quick overview
The half-life is about 5 days. By 5 d, half has left the body. Five half-lives equal 25 d, when about 3% remains.
In the 40-week SURPASS-1 trial, people with type 2 diabetes lost 7.8 kg, compared with 1 kg on placebo.
The maker's price page provides monthly price points in US dollars for list prices and self-pay offers.
Sources: FDA label (DailyMed), healthsystemtracker.org, pricinginfo.lilly.com.